NCT06998641

Brief Summary

This study was planned to investigate the efficacy of different treatment methods that can be used in the treatment of hemorrhagic tears that may occur in the postpartum period. The volunteers who will participate in the study will be evaluated during the hospitalization period after delivery and at the end of the puerperium 6 weeks after delivery, in accordance with routine postpartum control examinations. In the treatment of postpartum hemorrhagic tears, the treatment options such as suturing the tears to stop bleeding or applying tampons with bleeding stopping agent (chitosan) and compression effect to the torn area will be determined completely randomly.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Mar 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Mar 2025Dec 2028

Study Start

First participant enrolled

March 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

2 years

First QC Date

May 22, 2025

Last Update Submit

May 22, 2025

Conditions

Keywords

chitosan-covered-gauzepost-partum lacerationsobstetrical tears

Outcome Measures

Primary Outcomes (1)

  • Amount of bleeding

    Total amount of blood which is calculated by subtracting the dry weight of surgical absorbant gauze materials from their soaked weight

    From time of birth to the cessation of bleeding

Study Arms (2)

chitosan-covered-gauze applied tears

EXPERIMENTAL

Hemostasis of the tears is obtained by the application of chitosan-covered-gauze

Procedure: Chitosan-covered-gauze application

Suturation group

ACTIVE COMPARATOR

Hemostasis of the tears is obtained by suturing

Procedure: Suturation

Interventions

Effectiveness of chitosan-covered-gauze in terms of patients' comfort and satisfaction, hospital stay, total amount of bleeding, hemoglobin decline and other complications (infections, need for transfusion etc.) for the treatment of hemorrhagic obstetrical tears

chitosan-covered-gauze applied tears
SuturationPROCEDURE

Effectiveness of suturation in terms of patients' comfort and satisfaction, hospital stay, total amount of bleeding, hemoglobin decline and other complications (infections, need for transfusion etc.) for the treatment of hemorrhagic obstetrical tears

Suturation group

Eligibility Criteria

Age18 Years - 48 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Training and Research Hospital Department of Obstetrics and Gynecology

Istanbul, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Maternal Fetal Medicine Specialist

Study Record Dates

First Submitted

May 22, 2025

First Posted

May 31, 2025

Study Start

March 1, 2025

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

December 1, 2028

Last Updated

May 31, 2025

Record last verified: 2025-05

Locations